Impact of concomitant proton pump inhibitor during oral anticoagulant treatment

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND/INTRODUCTION: Proton pump inhibitor is commonly used for gastroprotective effect in patients with a combination of antiplatelets and anticoagulants. However, data quantifying the concomitant proton pump inhibitor for clinical advers...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, K N, Kim, D Y, Roh, S Y, Kim, H Y, Hwang, K S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
10.5.1 - Oral Anticoagulation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207436/
http://dx.doi.org/10.1093/europace/euad122.205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207436/
http://dx.doi.org/10.1093/europace/euad122.205

Ejemplares similares